Table III.
Composition for Assessing the Disintegration Mediated Controlled Release Design
| S. no. | Compositions | D1 | D2 | D3 | D4 | D5 |
|---|---|---|---|---|---|---|
| Ingredient | mg/tab | mg/tab | mg/tab | mg/tab | mg/tab | |
| 1 | CIL | 100.00 | 100.00 | |||
| 2 | PVP | 400.00 | 400.00 | |||
| 3 | SD (CIL:PVP::1:4) | 500.00 | 500.00 | |||
| 4 | HVO | 250.00 | 250.00 | 250.00 | 150.00 | 250.00 |
| 5 | NaCMC | 5.00 | 5.00 | 5.00 | 15.00 | 5.00 |
| 6 | MCC | 535.00 | 135.00 | 135.00 | 225.00 | 235.00 |
| 7 | Magnesium stearate | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Tablet weight | 900.00 | 900.00 | 900.00 | 900.00 | 900.00 |